(Q39954932)

15 September 2017

title

Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia (English)

1 reference

15 September 2017

poliovirus

1 reference

3

Cara Burns

1 reference

15 September 2017

15

Olen Kew

1 reference

15 September 2017

Shohreh Shahmahmoodi

1

1 reference

15 September 2017

Nima Parvaneh

2

1 reference

15 September 2017

Humayun Asghar

4

1 reference

15 September 2017

Setareh Mamishi

5

1 reference

15 September 2017

Hamideh Tabatabaie

6

1 reference

15 September 2017

Qi Chen

7

1 reference

15 September 2017

Shahram Teimourian

8

1 reference

15 September 2017

Mohammad Mehdi Gooya

9

1 reference

15 September 2017

Abdol-Reza Esteghamati

10

1 reference

15 September 2017

Taha Mousavi

11

1 reference

15 September 2017

Maryam Yousefi

12

1 reference

15 September 2017

Kobra Farrokhi

13

1 reference

15 September 2017

Maryam Mashlool

14

1 reference

15 September 2017

Rakhshandeh Nategh

16

1 reference

15 September 2017

publication date

15 August 2008

1 reference

15 September 2017

1 reference

15 September 2017

volume

137

1 reference

15 September 2017

issue

1

1 reference

15 September 2017

page(s)

168-172

1 reference

Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Polio eradication: the OPV paradox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Novel BTK mutation presenting with vaccine-associated paralytic poliomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Long-term excretion of vaccine-derived poliovirus by a healthy child

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

The molecular biology of poliovaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

The Temperature Sensitivity of the Sabin Type 3 Vaccine Strain of Poliovirus: Molecular and Structural Effects of a Mutation in the Capsid Protein VP3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Vaccine-associated paralytic poliomyelitis in a patient with MHC class II deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Studies on the attenuation phenotype of polio vaccines: poliovirus RNA polymerase derived from Sabin type 1 sequence is temperature sensitive in the uridylylation of VPg

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Characterisation of L cells expressing the human poliovirus receptor for the specific detection of polioviruses in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

The primary immunodeficiencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Serotype-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2008.07.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIRUSRES.2008.07.006

1 reference

15 September 2017

1 reference